Featured
Want to learn more about 7th Annual Conference in Japan for Asian New Drug Development? You've come to the right site!
Comité del programa
-
Kihito Takahashi Head of R&D/Medical Affairs Hub Japan
Swedish Orphan Biovitrium (SOBI) Japan, Japan -
Tetsuomi Takano, RPH Editor-in-Chief
Drug R&D Expert, Japan -
Yuko Kikuchi, MS, RPH Senior Director, Asia Regulatory Affairs
Eisai Co., Ltd., Japan -
Koichi Miyazaki, PHD Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan -
Junichi Nishino, MSC, RPH Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Yoshihiko Ono, RPH Regulatory Executive Advisor
MSD K.K., Japan -
Yasuto Otsubo Review Director, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Akio Uemura, PHD Senior Advisor
AU Consulting, Co., Japan -
Yoshiaki Uyama, PHD, MS, RPH Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
¿Tiene una cuenta?